Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Integrated systems-genetic analyses reveal a network target for delaying glioma progression.

Laaniste L, Srivastava PK, Stylianou J, Syed N, Cases-Cunillera S, Shkura K, Zeng Q, Rackham OJL, Langley SR, Delahaye-Duriez A, O'Neill K, Williams M, Becker A, Roncaroli F, Petretto E, Johnson MR.

Ann Clin Transl Neurol. 2019 Sep;6(9):1616-1638. doi: 10.1002/acn3.50850. Epub 2019 Aug 17.

2.

Multiple Posttranscriptional Strategies To Regulate the Herpes Simplex Virus 1 vhs Endoribonuclease.

Elliott G, Pheasant K, Ebert-Keel K, Stylianou J, Franklyn A, Jones J.

J Virol. 2018 Aug 16;92(17). pii: e00818-18. doi: 10.1128/JVI.00818-18. Print 2018 Sep 1.

3.

Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.

Kelly GL, Stylianou J, Rasaiyaah J, Wei W, Thomas W, Croom-Carter D, Kohler C, Spang R, Woodman C, Kellam P, Rickinson AB, Bell AI.

J Virol. 2013 Mar;87(5):2882-94. doi: 10.1128/JVI.03003-12. Epub 2012 Dec 26.

4.

A network of protein interactions around the herpes simplex virus tegument protein VP22.

Maringer K, Stylianou J, Elliott G.

J Virol. 2012 Dec;86(23):12971-82. doi: 10.1128/JVI.01913-12. Epub 2012 Sep 19.

5.

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.

Kelly GL, Long HM, Stylianou J, Thomas WA, Leese A, Bell AI, Bornkamm GW, Mautner J, Rickinson AB, Rowe M.

PLoS Pathog. 2009 Mar;5(3):e1000341. doi: 10.1371/journal.ppat.1000341. Epub 2009 Mar 13.

6.

Virion incorporation of the herpes simplex virus type 1 tegument protein VP22 occurs via glycoprotein E-specific recruitment to the late secretory pathway.

Stylianou J, Maringer K, Cook R, Bernard E, Elliott G.

J Virol. 2009 May;83(10):5204-18. doi: 10.1128/JVI.00069-09. Epub 2009 Mar 11.

7.

Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.

Hutchings IA, Tierney RJ, Kelly GL, Stylianou J, Rickinson AB, Bell AI.

J Virol. 2006 Nov;80(21):10700-11. Epub 2006 Aug 18.

8.

Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB.

Stylianou J, Vowels M, Hadfield K.

Cytotherapy. 2006;8(1):57-61.

PMID:
16627345

Supplemental Content

Loading ...
Support Center